Showing 2881-2890 of 3876 results for "".
- Nearly 10.5 Million Treatments Performed by ASDS Members in 2016https://modernaesthetics.com/news/nearly-105-million-treatments-performed-by-asds-members-in-2016/2472226/Dermatologic surgeons performed nearly 10.5 million medically necessary and cosmetic procedures in 2016 – five percent more than 2015 and up 31 percent since 2012, according to the 2016 American Society for Dermatologic Surgery (ASDS) Survey on D
- ThermiGen, an Almirall company, Names Vladimir Paul-Blanc President & General Managerhttps://modernaesthetics.com/news/thermigen-an-almirall-company-names-vladimir-paul-blanc-president-general-manager/2472245/Vladimir Paul-Blanc has been named President & General Manager of ThermiGen, LLC, starting May 1. He will report directly to the Executive Vice-president of Commercial Strategy of Almirall, Alfonso Ugarte, and he will be responsible for all general management responsibilities for the Thermi b
- ASAPS 2016: Labiaplasty More Than A Fadhttps://modernaesthetics.com/news/asaps-2016-labiaplasty-more-than-a-fad/2472263/When it rains, it pours. Both the American Society of Plastic Surgeons (ASPS) and sister organization American Society for Aesthetic Plastic Surgery (ASAPS) released some (ASAPS) or all (ASPS) of their annual statistics. And by and
- Cynosure to Be Acquired by Hologichttps://modernaesthetics.com/news/cynosure-to-be-acquired-by-hologic/2472278/Hologic, Inc. and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65 billion
- Allergan Agrees to Acquire ZELTIQ for $2.47 Billionhttps://modernaesthetics.com/news/allergan-agrees-to-acquire-zeltiq-for-247-billion/2472280/Allergan plc and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary
- Allergan Launches Juvéderm Volitehttps://modernaesthetics.com/news/allergan-launches-juvderm-volite/2472287/Allergan plc launched Juvéderm Volite, an injectable product specifically designed to improve skin quality and last up to nine months with just one treatment session. This innovative new Allergan product uses the unique patented Vycross technology. The new HA injectable treatment d
- Happy 10th Birthday Radiesse!https://modernaesthetics.com/news/happy-10th-birthday-radiesse/2472291/Merz Aesthetics’ flagship brand, Radiesse, turned 10 this year, and was feted in style at a throw-back Thursday media event in New York City. The party took beauty bloggers and journos back to 2007 when the first iPhone was releas
- FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”https://modernaesthetics.com/news/fda-approves-restylane-refyne-and-restylane-defyne-dermal-fillers-for-laugh-lines/2472303/The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane®
- Brian Biesmanhttps://modernaesthetics.com/profiles/brian-biesman/Owdd94/
- Brian Biesman, MDhttps://modernaesthetics.com/profiles/brian-biesman-md/LzeDeG/